Page last updated: 2024-08-25

asperuloside and mocetinostat

asperuloside has been researched along with mocetinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, C; Chi, G; Feng, H; Qiu, J; Ren, Y; Wu, Q	1

Other Studies

1 other study(ies) available for asperuloside and mocetinostat

Article	Year
Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model. International immunopharmacology, 2016, Volume: 31 Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cell Line; Cyclopentane Monoterpenes; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Humans; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peroxidase; Pyrans; Signal Transduction; Tumor Necrosis Factor-alpha	2016

Article

Year

Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model.

International immunopharmacology, 2016, Volume: 31

Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cell Line; Cyclopentane Monoterpenes; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Humans; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peroxidase; Pyrans; Signal Transduction; Tumor Necrosis Factor-alpha

2016